Website Banner Farcast Bio.png

INCREASING PREDICTABILITY IN PRECISION CANCER TREATMENT 

 

True Tumor Microenvironment Mapping

The Farcast platform enables a holistic view and a deeper understanding of the complexities of human cancer

 

Within a few hours of harvesting fresh human tumors, proprietary methods are used to fragment and culture living tumor fragments ex-vivo for up to 72 hours

 

The proprietary techniques ensure preservation of the entire tumor architecture maintaining morphology and spatial architecture of tumor fragments, while retaining the functional fidelity of tumor, immune and stromal components

 

Farcast's unique ability to create optimally sized tumor fragments enables the interrogation and evaluation of true responses in realistic human tumor microenvironment

 

Combined with sophisticated algorithms, the whole system leads to higher accuracy of predicted therapy response compared with cell-line or animal or tumoroid models

iStock-1385929874.png

TruNet

Trusted relationships with cancer centers who share our vision to help patients do better

iStock-1385930533.png

TruTumor

True representation of human tumors ex-vivo retaining spatial arrangement of tumor, immune and stromal components

iStock-1385930831.png

TruTERM

Tumor Environment Response Maps that intelligently combine multi-omics using AI algorithms

iStock-1385673803.png

TruSign

Unique signatures for precise understanding of therapeutic response

LA1_CD68op520_CD3_op570_CD8_op690_panCKAF750_20X -10.bmp

TruTumor Culture

 Preserving native spatial contexture in human tumor microenvironment

 Representing tumor heterogeneity

 Simultaneous comparison of multiple therapies for every patient tumor

 Orthogonal assays to assess response

 panCK CD8 CD3 CD68 Nucleus

Farcast proprietary image 

Farcast Is Helping Unravel The Truths of Tumor Microenvironments

SITC TME 2022: Elucidating the difference between peripheral blood immune cell and Intratumoral Immune Cells (IICs) 
AACR 2022: Differential T-cell Response in different indications
SITC 2021: Selective infiltration of  ADCC mediating immune cells in response to treatment